MIPS Molecular Imaging Program at Stanford

2015 MIPS Molecular Imaging Seminar Series

Calendars and Scheduling

Use the links below to view event calendars and the availability and schedules of rooms.

 
Seminar 5:30 − 6:15 pm
Discussion 6:15 − 6:30 pm
Reception 6:30 − 7:00 pm
Li Ka Shing Center, Rm. LK130
Stanford University Campus

You will need the free QuickTime Player QuickTime logo
to view the webcast of lectures.

Invited Speakers
January 9, 2015 Robert Grubbs, PhD
February 3, 2015 Hyunsuk Shim, PhD - View Webcast
March 5, 2015 Garry Nolan, PhD - View Webcast
April 2, 2015 Mikhail G. Shapiro, PhD
May 7, 2015 Zahi A. Fayad, PhD, FAHA, FACC, FISMRMD - View Webcast
June 2015 (no seminar) Summer Hiatus
July 2015 (no seminar) Summer Hiatus
August 2015 (no seminar) Summer Hiatus
September 3, 2015 TBD
October 1, 2015 TBD
November 5, 2015 TBD
December 3, 2015 TBD

 

Jan 9, 2015
12:30-1:30pm
Munzer


Photo of Robert Grubbs, PhD
Robert Grubbs, PhD

Victor and Elizabeth Atkins Professor of Chemistry
CalTech
Adventures in the Development of Materials for Clinical Applications

Abstract
The Grubbs group discovers new catalysts and studies their fundamental chemistry and applications. Catalysts facilitate the transformation of organic molecules and are used widely in industry and academia for the preparation of important organic compounds and polymers. A family of catalysts for the interconversion of olefins, the olefin metathesis reaction has been discovered in the Grubbs laboratory. In addition to their broad usage in academic research, these catalysts are now used commercially to prepare new pharmaceuticals, composites for structural applications and for the conversion of biorenewable carbon sources into fuels and commodity chemicals. Catalysts for other useful transformations are also being developed and studied in detail.

His more recent awards have included the Nobel Prize in Chemistry (2005), Benjamin Franklin Medal in Chemistry (2000), Pauling Award Medal 2003), Havinga Medal (2006) (Leiden University), Golden Plate Award (2006) (Academy of Achievement), Gold Medal of the American Institute of Chemists (2010) 8 ACS Awards including: Polymer Chemistry (1995), Arthur C. Cope Award (2002), Award for Creative Invention (2009), ACS Roger Adams Award in Organic Chemistry (2011), Giulio Natta Award for Chemistry (2014). He was elected to the National Academy of Sciences (1989), Fellow of the American Academy of Arts and Sciences (1994), the Honorary Fellowship of the Royal Society of Chemistry (2006), Fellows of the American Chemical Society (2009), ACS Polymer Division Fellow (2010), Gold Medal of the American Institute of Chemists, Chemical Heritage Foundation (2010). He has been awarded many honorary degrees, the most recent being an Honorary Degree of DSc from University of Warwick, Coventry (2010), Honors Causa Doctrorate, Univerdidad de Huelva, Spain (2012), Commencement Speaker at KAUST, Jeddah, SA (2012), and RWTH Aachen University Honorary Doctorate (Dr.rer.nat.h.c.) (2013). He has 580+ publications and 129+ patents based on his research.
Feb 3, 2015
Munzer

Photo of Hyunsuk Shim
Hyunsuk Shim, PhD

Department of Radiology and Imaging Sciences
Emory University

View Webcast
Emory QIN: The use of high resolution volumetric MR spectroscopic imaging in the management of glioblastoma

Abstract
The objective of Emory QIN project is to establish quantitative, high resolution, volumetric magnetic resonance spectroscopic imaging (MRSI) as a primary biomarker for predicting and monitoring treatment response in human brain tumors. The technology will be applied to a trial of a promising histone deacetylase (HDAC) inhibitor, in combination with standard therapy in patients with glioblastoma (GBM). In addition, we apply our technology in surgical planning as well as radiation planning for GBM patients. GBM resection using neuronavigation based on contrast-enhanced MRI (CE-MRI) results in a high rate of local recurrence, as infiltrating tumor cells extend beyond areas of contrast enhancement. Integrating metabolic maps from MRSI into neuronavigation may identify high-risk tumor infiltration zones outside of CE-MRI for surgery. While CE-MRI images tumor vasculature, MRSI directly images tumor cells via their altered metabolism. Coupling MRSI with fluorescence-guided surgery (FGS) using 5-aminolevulinic acid (5-ALA) may provide a means to enhance the degree of tumor resection further.
Mar 5, 2015
Munzer

Photo of Garry Nolan, PhD
Garry Nolan, PhD

Rachford and Carlota A. Harris Professor
Dir, NHLBI Proteomics Center for Systems Immunology
Baxter Lab for Stem Cell Bio
Stanford School of Medicine View Webcast
Next Steps in High Parameter Imaging and Single Cell Analysis

Abstract
Dr. Nolan's laboratory works on a number of single cell analysis and imaging approaches.  I will discuss recent advances in multiparameter mass based detection of cellular components (proteins, mRNA, protein-DNA contacts) in flow cytometric and histology based platforms using CyTOF and MIBI.  I will detail research (iPS cells) and clinical applications (immune based detection of trauma & recovery, AML) as well as computational approaches to analyze the data produced on these and other high parameter platforms we are developing.
Apr 3, 2015
Munzer

Photo of Mikhail Shapiro
Mikhail G. Shapiro, PhD

Assist Prof, Chem Eng
CalTech
Biomolecular Engineering for Non-invasive Imaging of Biological Function

Abstract
Many important biological processes – ranging from simple metabolism to complex cognition – take place deep inside living organisms, yet our ability to study them in this context is very limited. Technologies such as fluorescent proteins and optogenetics enable exquisitely precise imaging and control of cellular function in small, translucent specimens using visible light, but are limited by the poor penetration of such light into larger tissues. In contrast, most non-invasive technologies such as magnetic resonance imaging (MRI) and ultrasound – while based on energy forms that penetrate tissue effectively – lack the needed molecular precision. Our work attempts to bridge this gap by engineering new molecular technologies that connect penetrant energy to specific aspects of cellular function in vivo. In this talk, I will describe molecular reporters for non-invasive imaging using MRI and ultrasound developed by adapting and engineering naturally occurring proteins. These proteins have physical properties, such as paramagnetism or self-assembly into hollow nanostructures, that allow them to be sensitively detected with MRI and ultrasound. By engineering them at the genetic level, we have adapted these natural constructs into non-invasive molecular reporters of biological processes ranging from gene expression to chemical neurotransmission.
May 7, 2015
Munzer

Photo of Zahi Fayad
Zahi A. Fayad, PhD, FAHA, FACC, FISMRM

Prof, Rad & Med (Card)
Dir, Translational and Molecular Institute
Vice chair for Research, Rad
Mount Sinai, New York, NY
View Webcast

Imaging and Nanomedicine in Inflammatory Atherosclerosis

Abstract
Atherosclerosis is a chronic progressive disease, affecting the medium and large arteries, in which lipid-triggered inflammation plays a pivotal role. The major clinical manifestations of atherosclerosis are coronary artery disease (CAD), leading to acute myocardial infarction (MI) and sudden cardiac death; cerebrovascular disease, leading to stroke; and peripheral arterial disease, leading to ischemic limbs and viscera. These complications of atherosclerosis are leading causes of death worldwide. Despite progress in medical and revascularization therapies for atherothrombotic disease, the incidence of MI and stroke remain high under the current standard of care, and the past decade has generated few new medical therapies to prevent atherosclerosis-induced events. Similarly, current diagnostic approaches to atherosclerosis do not accurately identify those individuals who will suffer an ischemic complication. The field of atherosclerosis is therefore ripe for reengineering in both the therapeutic and diagnostic arenas. Research into the process of atheroma lesion development and maturation has implicated many immune cells including lymphocytes, dendritic cells, and neutrophils. The most numerous cells in atherosclerotic plaque are macrophages, which are leukocytes that are central to the innate immunity. Because they play a major role in instigating plaque development and complication—both of which are inflammation-related disease processes—leukocytes are promising targets for more effective atherosclerosis treatments. However, the complexity of the immune system and its role as a defensive force against infection require novel tools to very precisely identify and treat the inflammatory cells that promote atherosclerosis. Biomedical engineering offers unique possibilities for diagnosing and treating atherosclerotic plaque inflammation. Thus, interfacing engineering with immunology will be essential to meaningful advances in disease management.
Sept 3, 2015
Munzer

TBD
TBD
Oct 1, 2015
Munzer

TBD
TBD
Nov 5, 2015
Munzer

TBD
TBD
Dec 3, 2015
Munzer

TBD
TBD

Sponsored by: Molecular Imaging Program at Stanford (MIPS) (mips.stanford.edu);
Host: Director, Sanjiv Sam Gambhir, MD, PhD (sgambhir@stanford.edu)

If you would like to be included on the MIPS email distribution list for weekly meeting reminders, contact Susan Singh.

Footer Links: